US 10730882
2-aminoquinazoline derivatives as P70S6 kinase inhibitors
granted A61PA61P25/28A61P35/04
Quick answer
US patent 10730882 (2-aminoquinazoline derivatives as P70S6 kinase inhibitors) held by SENTINEL ONCOLOGY LIMITED expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SENTINEL ONCOLOGY LIMITED
- Grant date
- Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P25/28, A61P35/04